NEUP vs XLI
Neuphoria Therapeutics Inc (NEUP) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
XLI (XLI) common stock.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
XLI does not have a complete income-statement cache yet.
NEUP currently screens at market cap $23.6M. XLI currently screens at market cap $0.
Not investment advice. Open the NEUP and XLI stock pages for the full models.
Not investment advice.